Global and China Drug Repurposing Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19231535 | Publishing Date : 27-Sep-2021 | No. of pages : 99
Detailed TOC of Global and China Drug Repurposing Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Drug Repurposing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular Disorders
1.3.3 Central Nervous Disorders
1.3.4 Oncology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drug Repurposing Market Perspective (2016-2027)
2.2 Drug Repurposing Growth Trends by Regions
2.2.1 Drug Repurposing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drug Repurposing Historic Market Share by Regions (2016-2021)
2.2.3 Drug Repurposing Forecasted Market Size by Regions (2022-2027)
2.3 Drug Repurposing Industry Dynamic
2.3.1 Drug Repurposing Market Trends
2.3.2 Drug Repurposing Market Drivers
2.3.3 Drug Repurposing Market Challenges
2.3.4 Drug Repurposing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Repurposing Players by Revenue
3.1.1 Global Top Drug Repurposing Players by Revenue (2016-2021)
3.1.2 Global Drug Repurposing Revenue Market Share by Players (2016-2021)
3.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug Repurposing Revenue
3.4 Global Drug Repurposing Market Concentration Ratio
3.4.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2020
3.5 Drug Repurposing Key Players Head office and Area Served
3.6 Key Players Drug Repurposing Product Solution and Service
3.7 Date of Enter into Drug Repurposing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Repurposing Breakdown Data by Type
4.1 Global Drug Repurposing Historic Market Size by Type (2016-2021)
4.2 Global Drug Repurposing Forecasted Market Size by Type (2022-2027)
5 Drug Repurposing Breakdown Data by Application
5.1 Global Drug Repurposing Historic Market Size by Application (2016-2021)
5.2 Global Drug Repurposing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Drug Repurposing Market Size (2016-2027)
6.2 North America Drug Repurposing Market Size by Type
6.2.1 North America Drug Repurposing Market Size by Type (2016-2021)
6.2.2 North America Drug Repurposing Market Size by Type (2022-2027)
6.2.3 North America Drug Repurposing Market Size by Type (2016-2027)
6.3 North America Drug Repurposing Market Size by Application
6.3.1 North America Drug Repurposing Market Size by Application (2016-2021)
6.3.2 North America Drug Repurposing Market Size by Application (2022-2027)
6.3.3 North America Drug Repurposing Market Size by Application (2016-2027)
6.4 North America Drug Repurposing Market Size by Country
6.4.1 North America Drug Repurposing Market Size by Country (2016-2021)
6.4.2 North America Drug Repurposing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Drug Repurposing Market Size (2016-2027)
7.2 Europe Drug Repurposing Market Size by Type
7.2.1 Europe Drug Repurposing Market Size by Type (2016-2021)
7.2.2 Europe Drug Repurposing Market Size by Type (2022-2027)
7.2.3 Europe Drug Repurposing Market Size by Type (2016-2027)
7.3 Europe Drug Repurposing Market Size by Application
7.3.1 Europe Drug Repurposing Market Size by Application (2016-2021)
7.3.2 Europe Drug Repurposing Market Size by Application (2022-2027)
7.3.3 Europe Drug Repurposing Market Size by Application (2016-2027)
7.4 Europe Drug Repurposing Market Size by Country
7.4.1 Europe Drug Repurposing Market Size by Country (2016-2021)
7.4.2 Europe Drug Repurposing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Drug Repurposing Market Size (2016-2027)
8.2 Asia-Pacific Drug Repurposing Market Size by Type
8.2.1 Asia-Pacific Drug Repurposing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drug Repurposing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drug Repurposing Market Size by Type (2016-2027)
8.3 Asia-Pacific Drug Repurposing Market Size by Application
8.3.1 Asia-Pacific Drug Repurposing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drug Repurposing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drug Repurposing Market Size by Application (2016-2027)
8.4 Asia-Pacific Drug Repurposing Market Size by Region
8.4.1 Asia-Pacific Drug Repurposing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drug Repurposing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drug Repurposing Market Size (2016-2027)
9.2 Latin America Drug Repurposing Market Size by Type
9.2.1 Latin America Drug Repurposing Market Size by Type (2016-2021)
9.2.2 Latin America Drug Repurposing Market Size by Type (2022-2027)
9.2.3 Latin America Drug Repurposing Market Size by Type (2016-2027)
9.3 Latin America Drug Repurposing Market Size by Application
9.3.1 Latin America Drug Repurposing Market Size by Application (2016-2021)
9.3.2 Latin America Drug Repurposing Market Size by Application (2022-2027)
9.3.3 Latin America Drug Repurposing Market Size by Application (2016-2027)
9.4 Latin America Drug Repurposing Market Size by Country
9.4.1 Latin America Drug Repurposing Market Size by Country (2016-2021)
9.4.2 Latin America Drug Repurposing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Repurposing Market Size (2016-2027)
10.2 Middle East & Africa Drug Repurposing Market Size by Type
10.2.1 Middle East & Africa Drug Repurposing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drug Repurposing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drug Repurposing Market Size by Type (2016-2027)
10.3 Middle East & Africa Drug Repurposing Market Size by Application
10.3.1 Middle East & Africa Drug Repurposing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drug Repurposing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drug Repurposing Market Size by Application (2016-2027)
10.4 Middle East & Africa Drug Repurposing Market Size by Country
10.4.1 Middle East & Africa Drug Repurposing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drug Repurposing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Drug Repurposing Introduction
11.1.4 Pfizer Revenue in Drug Repurposing Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Drug Repurposing Introduction
11.2.4 Roche Revenue in Drug Repurposing Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Drug Repurposing Introduction
11.3.4 Novartis AG Revenue in Drug Repurposing Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Abbott Healthcare
11.4.1 Abbott Healthcare Company Details
11.4.2 Abbott Healthcare Business Overview
11.4.3 Abbott Healthcare Drug Repurposing Introduction
11.4.4 Abbott Healthcare Revenue in Drug Repurposing Business (2016-2021)
11.4.5 Abbott Healthcare Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Drug Repurposing Introduction
11.5.4 Johnson & Johnson Revenue in Drug Repurposing Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Sandoz
11.6.1 Sandoz Company Details
11.6.2 Sandoz Business Overview
11.6.3 Sandoz Drug Repurposing Introduction
11.6.4 Sandoz Revenue in Drug Repurposing Business (2016-2021)
11.6.5 Sandoz Recent Development
11.7 Mylan Inc.
11.7.1 Mylan Inc. Company Details
11.7.2 Mylan Inc. Business Overview
11.7.3 Mylan Inc. Drug Repurposing Introduction
11.7.4 Mylan Inc. Revenue in Drug Repurposing Business (2016-2021)
11.7.5 Mylan Inc. Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Details
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Drug Repurposing Introduction
11.8.4 Teva Pharmaceuticals Revenue in Drug Repurposing Business (2016-2021)
11.8.5 Teva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and China Drug Repurposing Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Drug Repurposing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous
Table 3. Key Players of Oral
Table 4. Global Drug Repurposing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Drug Repurposing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Drug Repurposing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Drug Repurposing Market Share by Regions (2016-2021)
Table 8. Global Drug Repurposing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Drug Repurposing Market Share by Regions (2022-2027)
Table 10. Drug Repurposing Market Trends
Table 11. Drug Repurposing Market Drivers
Table 12. Drug Repurposing Market Challenges
Table 13. Drug Repurposing Market Restraints
Table 14. Global Drug Repurposing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Drug Repurposing Market Share by Players (2016-2021)
Table 16. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Repurposing as of 2020)
Table 17. Ranking of Global Top Drug Repurposing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Drug Repurposing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug Repurposing Product Solution and Service
Table 21. Date of Enter into Drug Repurposing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Repurposing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Drug Repurposing Revenue Market Share by Type (2016-2021)
Table 25. Global Drug Repurposing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Drug Repurposing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Drug Repurposing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Drug Repurposing Revenue Market Share by Application (2016-2021)
Table 29. Global Drug Repurposing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Drug Repurposing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Drug Repurposing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Drug Repurposing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Drug Repurposing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Drug Repurposing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Drug Repurposing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Drug Repurposing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Drug Repurposing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Drug Repurposing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Drug Repurposing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Drug Repurposing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Drug Repurposing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Drug Repurposing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Drug Repurposing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Drug Repurposing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Drug Repurposing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Drug Repurposing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Drug Repurposing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Drug Repurposing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Drug Repurposing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Drug Repurposing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Drug Repurposing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Drug Repurposing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Drug Repurposing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Drug Repurposing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Drug Repurposing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Drug Repurposing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Drug Repurposing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Drug Repurposing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Drug Repurposing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Drug Repurposing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Drug Repurposing Product
Table 64. Pfizer Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Drug Repurposing Product
Table 69. Roche Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Novartis AG Company Details
Table 72. Novartis AG Business Overview
Table 73. Novartis AG Drug Repurposing Product
Table 74. Novartis AG Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 75. Novartis AG Recent Development
Table 76. Abbott Healthcare Company Details
Table 77. Abbott Healthcare Business Overview
Table 78. Abbott Healthcare Drug Repurposing Product
Table 79. Abbott Healthcare Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 80. Abbott Healthcare Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Drug Repurposing Product
Table 84. Johnson & Johnson Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. Sandoz Company Details
Table 87. Sandoz Business Overview
Table 88. Sandoz Drug Repurposing Product
Table 89. Sandoz Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 90. Sandoz Recent Development
Table 91. Mylan Inc. Company Details
Table 92. Mylan Inc. Business Overview
Table 93. Mylan Inc. Drug Repurposing Product
Table 94. Mylan Inc. Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 95. Mylan Inc. Recent Development
Table 96. Teva Pharmaceuticals Company Details
Table 97. Teva Pharmaceuticals Business Overview
Table 98. Teva Pharmaceuticals Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 99. Teva Pharmaceuticals Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Repurposing Market Share by Type: 2020 VS 2027
Figure 2. Intravenous Features
Figure 3. Oral Features
Figure 4. Global Drug Repurposing Market Share by Application: 2020 VS 2027
Figure 5. Cardiovascular Disorders Case Studies
Figure 6. Central Nervous Disorders Case Studies
Figure 7. Oncology Case Studies
Figure 8. Others Case Studies
Figure 9. Drug Repurposing Report Years Considered
Figure 10. Global Drug Repurposing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Drug Repurposing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Drug Repurposing Market Share by Regions: 2020 VS 2027
Figure 13. Global Drug Repurposing Market Share by Regions (2022-2027)
Figure 14. Global Drug Repurposing Market Share by Players in 2020
Figure 15. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Repurposing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Drug Repurposing Revenue in 2020
Figure 17. Global Drug Repurposing Revenue Market Share by Type (2016-2021)
Figure 18. Global Drug Repurposing Revenue Market Share by Type (2022-2027)
Figure 19. North America Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Drug Repurposing Market Share by Type (2016-2027)
Figure 21. North America Drug Repurposing Market Share by Application (2016-2027)
Figure 22. North America Drug Repurposing Market Share by Country (2016-2027)
Figure 23. United States Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Drug Repurposing Market Share by Type (2016-2027)
Figure 27. Europe Drug Repurposing Market Share by Application (2016-2027)
Figure 28. Europe Drug Repurposing Market Share by Country (2016-2027)
Figure 29. Germany Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Drug Repurposing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Drug Repurposing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Drug Repurposing Market Share by Region (2016-2027)
Figure 39. China Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Drug Repurposing Market Share by Type (2016-2027)
Figure 47. Latin America Drug Repurposing Market Share by Application (2016-2027)
Figure 48. Latin America Drug Repurposing Market Share by Country (2016-2027)
Figure 49. Mexico Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Drug Repurposing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Drug Repurposing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Drug Repurposing Market Share by Country (2016-2027)
Figure 55. Turkey Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 60. Novartis AG Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 61. Abbott Healthcare Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 63. Sandoz Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 64. Mylan Inc. Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 65. Teva Pharmaceuticals Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Keyplayers in Global and China Drug Repurposing Market Size, Status and Forecast 2021-2027
PfizerRoche
Novartis AG
Abbott Healthcare
Johnson & Johnson
Sandoz
Mylan Inc.
Teva Pharmaceuticals